Tivicay Latest News

A new HIV medication, Tivicay (dolutegravir) was approved this month by the FDA for use in combination with standard HIV regimens.

Tivicay is part of a class of anti-HIV drugs known as integrase inhibitors. These drugs work by preventing the activity of an enzyme necessary for the virus to multiply in cells. The only other medication available in this class is Isentress (raltegravir).

Tivicay has been approved for the use in patients with HIV-1 in combination with standard HIV regimens. See More

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.